Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)

The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program.

ARPA-H anticipates multiple awards and award types will result from this announcement.Interested

credit:


parties are invited to review attached APECx Research & Development Solicitation No.

75N99224R0000 1. Abstracts are due December 15, 2023, 9:00 AM ET.

Proposals will be invite-only and will be due February 16, 2024, 5:00 PM ET.

An abstract must be submitted to be invited to submit a proposal.Please ensure to follow this opportunity for any updates.For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/.Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program.
Agency: Department of Health and Human Services

Office: Advanced Research Projects Agency for Health

Estimated Funding: $0


Who's Eligible





Obtain Full Opportunity Text:
SAM.Gov link to the RDS

Additional Information of Eligibility:
Please see BAA for eligibility information.

Full Opportunity Web Address:
https://sam.gov/opp/6254723d96854573a6643803eefcf3c1/view

Contact:


Agency Email Description:
The APECx Team

Agency Email:


Date Posted:
2023-11-21

Application Due Date:


Archive Date:
2024-02-18


In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.






More Federal Domestic Assistance Programs


State Fiscal Stabilization Fund (SFSF) What Works and Innovation Fund, Recovery Act | Indian Housing Assistance | Polar Programs | Volcano Hazards Program Research and Monitoring. | Economic Development_Technical Assistance |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2025 Copyright Michael Saunders